Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial

Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial ntaylor Wed, 09/11/2024 - 09:51